Morphinan-6-ol,7,8-didehydro-4,5-epoxy-3- methoxy-17-methyl-,(5R,6R)-,phosphate (1:1) (salt),mixt. with (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3- yl R-(hydroxymethyl)benzeneacetate sulfate (2:1) (salt),sodium [(2,3-dihydro-1,5-dimethyl-3- oxo-2-phenyl-1H-pyrazol-4-yl)methylamino]- methanesulfonate and N,N,R-trimethyl-10H-phenothiazine-10- ethanamine monohydrochloride (76130-38-6)

Other Product

• Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, phosphate (1:1) (salt), mixt. with endo-(+-)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl alpha-(hydroxymethyl)benzeneacetate sulfate (2:1) (salt), sodium ((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methylamino)methanesulfonate and N,N,alpha-trimethyl-10H-phenothiazine-10-ethanamine
• Morphinan-6-ol,7,8-didehydro-4,5-epoxy-3- methoxy-17-methyl-,hydrochloride,(5R,6R)-,mixt. with 10-[(dimethylamino)acetyl]-10Hphenothiazine,(3-endo)-3-[(hydroxyphenylacetyl) oxy]-8,8-dimethyl-8-azoniabicyclo[3.2.1]- octane bromide and sodium [(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl- 1H-pyrazol-4-yl)methylamino]- methanesulfonate
• Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-, hydrochloride, mixt. with (7S-(7alpha,7aalpha,14alpha,14abeta))-dodecahydro-7,14-methano-2H,6H-dipyrido(1,2-a:1,2-e)(1,5)diazocine sulfate (1:1) and endo-(+-)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl-alpha-(hydroxymethyl)benzeneacetate sulfate (2:1) (salt)
• Ethanaminium, 2-(1-bicyclo(2.2.1)hept-5-en-2-yl-1-phenylethoxy)-N,N-diethyl-N-methyl-, bromide, mixt. with 7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol (5alpha,6alpha)-, phosphate (1:1) (salt), and sodium ((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methylamino)methanesulfonate
• Pyridinium,2-[(hydroxyimino)methyl]-1- methyl-,iodide,mixt. with 2-(diethylamino)ethyl R-hydroxy-R-phenylbenzeneacetate and (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3- yl R-(hydroxymethyl)benzeneacetate
• Morphinan-6-ol,7,8-didehydro-4,5-epoxy-3- methoxy-17-methyl-,(5R,6R)-,phosphate (1:1) (salt),mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione,4-(dimethylamino)-1,2-dihydro-1,5- dimethyl-2-phenyl-3H-pyrazol-3-one,N-(4-ethoxyphenyl)acetamide and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)- pyrimidinetrione
• Morphinan-6-ol,7,8-didehydro-4,5-epoxy-3- methoxy-17-methyl-,(5R,6R)-,phosphate (1:1) (salt),mixt. with 2-(acetyloxy)benzoic acid and N-(4-hydroxyphenyl)acetamide
• Morphinan-6-ol,7,8-didehydro-4,5-epoxy-3- methoxy-17-methyl-,(5R,6R)-,phosphate (1:1) (salt),mixt. with 2-hydroxybenzamide and N-(4-hydroxyphenyl)acetamide
• Methanesulfonic acid,[(2,3-dihydro-1,5- dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)- methylamino]-,sodium salt,mixt. with 8-chloro-3,7-dihydro-1,3-dimethyl-1Hpurine- 2,6-dione,2-chloro-N,N-dimethyl-10H-phenothiazine- 10-propanamine monohydrochloride,5,5-diethyl-2,4,6(1H,3H,5H)-pyrimidinetrione,4-(dimethylamino)-1,2-dihydro-1,5- dimethyl-2-phenyl-3H-pyrazol-3-one and N,N,R-trimethyl-10H-phenothiazine-10- ethanamine monohydrochloride
• 8-Azoniabicyclo[3.2.1]octane,3-(3-hydroxy-1- oxo-2-phenylpropoxy)-8,8-dimethyl-,(3- endo)-,nitrate (salt),mixt. with 1-[(3,4-dimethoxyphenyl)methyl]-6,7- dimethoxyisoquinoline hydrochloride and sodium [(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl- 1H-pyrazol-4-yl)methylamino]- methanesulfonate
• 5-oxo-L-proline, compound with endo-()-8-methyl-8-azabicyclo[3.2.1]oct-3-yl α-(hydroxymethyl)benzeneacetate (1:2)
• 5-oxo-L-proline, compound with endo-()-8-methyl-8-azabicyclo[3.2.1]oct-3-yl α-(hydroxymethyl)benzeneacetate (1:1)
• 3-Quinolinecarboxamide, 1,2-dihydro-4-hydroxy-N-(8-methyl-8-azabicyclo(3.2.1)oct-3-yl)-2-oxo-1-phenyl-, endo-, (E)-2-butenedioate, hydrate (1:1:2) (salt)
• Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, phosphate (1:1) (salt), mixt. with 2-(acetyloxy)benzoic acid and N-(4-ethoxyphenyl)acetamide
• Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, phosphate (1:1) (salt), mixt. with 2-(acetyloxy)benzoic acid, 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
• Morphinan-6-ol, 4,5-epoxy-3-methoxy-17-methyl-, (5-alpha,6-alpha)-, phosphate (1:1) (salt), mixt. with (R-(R*,S*))-alpha-(1-(methylamino)ethyl)benzenemethanol hydrochloride
• Morphinan-6-one,4,5-epoxy-14-hydroxy-3- methoxy-17-methyl-,hydrochloride,(5R)-,mixt. with (RS)-R-[(1R)-1-(methylamino)ethyl]- benzenemethanol hydrochloride and (1R,2â,4â,5R,7â)-9-methyl-3-oxa-9- azatricyclo[3.3.1.02,4]non-7-yl (RS)-R-(hydroxymethyl)benzeneacetate hydrobromide
• 8-Azoniabicyclo[3.2.1]octane,3-[(hydroxyphenylacetyl) oxy]-8,8-dimethyl-,bromide,(3-endo)-,mixt. with 1-[(3,4-diethoxyphenyl)methyl]-6,7- diethoxyisoquinoline hydrochloride,2-(diethylamino)-N-(2,6-dimethylphenyl)- acetamide monohydrochloride,5,5-di-2-propenyl-2,4,6(1H,3H,5H)- pyrimidinetrione and sodium [(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl- 1H-pyrazol-4-yl)methylamino]- methanesulfonate
• 3-Quinolinecarboxamide, 1-butyl-1,2-dihydro-4-hydroxy-N-(8-methyl-8-azabicyclo(3.2.1)oct-3-yl)-2-oxo-, endo-, (E)-2-butenedioate (1:2) (salt)
• Benzeneacetic acid,R-(hydroxymethyl)- (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3- yl ester,compounds,sulfate (1:1) (salt),mixt. with 1-[(3,4-dimethoxyphenyl)methyl]-6,7- dimethoxyisoquinoline sulfate (1:1)